Barry Wall published an interesting article with info related to the trial on TwiX:
https://x.com/HeadWarriorTWM/status/1990683481265876994
"Imagine a government health service, already condemned for rushing thousands of vulnerable children onto powerful puberty-blocking drugs with almost no evidence of safety or benefit, now announcing plans to start doing it again, this time deliberately framed as a “clinical trial”.
That is not a dystopian nightmare. It is NHS England’s actual policy in November 2025.
Eighteen months after the final Cass Review, published on 10 April 2024, demolished the evidence base for “gender-affirming care”, the same individuals and activist organisations that helped entrench the discredited model remain firmly in post.
Despite all evidence to the contrary, medical procedures touted as necessary and humane are still ongoing, not just for children, but also for mentally ill and paraphiliac adults, inflicting sex frauds and con merchants across all spheres of our existence.
Despite this Dr Michael Brady continues to serve as National Adviser for LGBT+ Health at NHS England, with echoes of Stonewall, the LGBT Foundation, WPATH and similar lobby groups still apparent.
Why has he not been fired?
Professor James Palmer remains National Medical Director for Specialised Services, personally responsible for commissioning the adult gender identity clinics that the Cass Review found to be operating on shockingly weak evidence. The eight new regional children’s gender services, ostensibly built on Cass recommendations, are already being shaped by many of the same activist organisations that helped create the Tavistock disaster.
Why has he not been fired?
Most outrageously, NHS England is pressing ahead with a planned clinical trial that will give puberty blockers to children diagnosed with so called "gender dysphoria" a fake diagnosis that means nothing, despite the Cass Review explicitly stating that the existing research is of such poor quality that no reliable conclusions can be drawn about either benefits or harms.
The review recommended that any future use of puberty blockers in children should occur only within a properly designed research protocol, an egregious error in an otherwise excellent report, positing that in some way a medical experiment with a 100% failure rate is ever justified.
The proposed trial lacks a clear hypothesis, has no established primary outcome measure that would justify restarting these interventions, and appears designed primarily to keep the door open for their eventual reintroduction rather than to answer genuine scientific questions."